ICH Q1 Stability Testing of New Drug Substances and Products

E555140

ICH Q1 Stability Testing of New Drug Substances and Products is an international regulatory guideline that defines the scientific principles and study requirements for assessing the stability, shelf life, and storage conditions of new pharmaceutical substances and finished products.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf ICH guideline
pharmaceutical stability guideline
regulatory guideline
abbreviatedAs ICH Q1 NERFINISHED
aimsTo ensure quality of pharmaceutical products over shelf life
harmonise stability testing requirements among ICH regions
support assignment of expiration dates for drug products
support assignment of retest periods for drug substances
appliesIn European Union NERFINISHED
Japan NERFINISHED
United States NERFINISHED
appliesTo marketed pharmaceutical products with significant changes
new chemical entities
new drug products
covers evaluation and extrapolation of stability data
relative humidity conditions for stability studies
requirements for stability testing after packaging changes
temperature conditions for stability studies
defines requirements for accelerated stability studies
requirements for intermediate stability studies
requirements for long-term stability studies
requirements for shelf life estimation
requirements for stability study design
requirements for stability testing of drug products in proposed container-closure systems
requirements for stability-indicating analytical methods
requirements for storage condition assignment
requirements for stress testing of drug substances
requirements for testing frequency in stability studies
hasPart ICH Q1A(R2) NERFINISHED
ICH Q1B NERFINISHED
ICH Q1C NERFINISHED
ICH Q1D NERFINISHED
ICH Q1E NERFINISHED
ICH Q1F NERFINISHED
issuedBy International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use NERFINISHED
language English
regulates stability testing of new drug products
stability testing of new drug substances
relatedTo Good Manufacturing Practice NERFINISHED
pharmaceutical quality by design
subjectOf ICH Q1A(R2): Stability Testing of New Drug Substances and Products NERFINISHED
ICH Q1B: Photostability Testing of New Drug Substances and Products NERFINISHED
ICH Q1C: Stability Testing for New Dosage Forms NERFINISHED
ICH Q1D: Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products NERFINISHED
ICH Q1E: Evaluation of Stability Data NERFINISHED
ICH Q1F: Stability Data Package for Registration Applications in Climatic Zones III and IV NERFINISHED
usedBy pharmaceutical companies
regulatory authorities in ICH regions

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

ICH notableGuideline ICH Q1 Stability Testing of New Drug Substances and Products